<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK247161" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK247161/" /><meta name="ncbi_pagename" content="PNPLA6-Related Disorders - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>PNPLA6-Related Disorders - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="PNPLA6-Related Disorders" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/06/11" /><meta name="citation_author" content="Matthis Synofzik" /><meta name="citation_author" content="Robert B Hufnagel" /><meta name="citation_author" content="Stephan Züchner" /><meta name="citation_pmid" content="25299038" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK247161/" /><meta name="citation_keywords" content="Spastic Paraplegia Type 39 (SPG39)" /><meta name="citation_keywords" content="Boucher-Neuhäuser Syndrome" /><meta name="citation_keywords" content="PNPLA6-Related Gordon Holmes Syndrome" /><meta name="citation_keywords" content="Oliver-McFarlane Syndrome" /><meta name="citation_keywords" content="PNPLA6-Related Laurence-Moon Syndrome" /><meta name="citation_keywords" content="Neuropathy target esterase" /><meta name="citation_keywords" content="PNPLA6" /><meta name="citation_keywords" content="PNPLA6-Related Disorders" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="PNPLA6-Related Disorders" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Matthis Synofzik" /><meta name="DC.Contributor" content="Robert B Hufnagel" /><meta name="DC.Contributor" content="Stephan Züchner" /><meta name="DC.Date" content="2015/06/11" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK247161/" /><meta name="description" content="PNPLA6-related disorders span a phenotypic continuum characterized by variable combinations of cerebellar ataxia, upper motor neuron involvement manifesting as spasticity and/or brisk reflexes, chorioretinal dystrophy associated with variable degrees of reduced visual function, and hypogonadotropic hypogonadism (delayed puberty and lack of secondary sex characteristics), either in isolation or as part of anterior hypopituitarism (growth hormone, thyroid hormone, or gonadotropin deficiencies). Common but less frequent features are peripheral neuropathy (usually of axonal type manifesting as reduced distal reflexes, diminished vibratory sensation, and/or distal muscle wasting), hair anomalies (long eyelashes, bushy eyebrows, or scalp alopecia), short stature, and impaired cognitive functioning (learning disabilities in children and deficits in attention, visuospatial abilities, and recall in adults). Some of these features can occur in distinct clusters on the phenotypic continuum: Boucher-Neuhäuser syndrome (cerebellar ataxia, chorioretinal dystrophy, and hypogonadotropic hypogonadism); Gordon Holmes syndrome (cerebellar ataxia, hypogonadotropic hypogonadism, and – to a variable degree – brisk reflexes); Oliver-McFarlane syndrome (trichomegaly, chorioretinal dystrophy, short stature, intellectual disability, and hypopituitarism); Laurence-Moon syndrome; and spastic paraplegia type 39 (SPG39) (upper motor neuron involvement, peripheral neuropathy, and sometimes reduced cognitive functioning and/or cerebellar ataxia)." /><meta name="og:title" content="PNPLA6-Related Disorders" /><meta name="og:type" content="book" /><meta name="og:description" content="PNPLA6-related disorders span a phenotypic continuum characterized by variable combinations of cerebellar ataxia, upper motor neuron involvement manifesting as spasticity and/or brisk reflexes, chorioretinal dystrophy associated with variable degrees of reduced visual function, and hypogonadotropic hypogonadism (delayed puberty and lack of secondary sex characteristics), either in isolation or as part of anterior hypopituitarism (growth hormone, thyroid hormone, or gonadotropin deficiencies). Common but less frequent features are peripheral neuropathy (usually of axonal type manifesting as reduced distal reflexes, diminished vibratory sensation, and/or distal muscle wasting), hair anomalies (long eyelashes, bushy eyebrows, or scalp alopecia), short stature, and impaired cognitive functioning (learning disabilities in children and deficits in attention, visuospatial abilities, and recall in adults). Some of these features can occur in distinct clusters on the phenotypic continuum: Boucher-Neuhäuser syndrome (cerebellar ataxia, chorioretinal dystrophy, and hypogonadotropic hypogonadism); Gordon Holmes syndrome (cerebellar ataxia, hypogonadotropic hypogonadism, and – to a variable degree – brisk reflexes); Oliver-McFarlane syndrome (trichomegaly, chorioretinal dystrophy, short stature, intellectual disability, and hypopituitarism); Laurence-Moon syndrome; and spastic paraplegia type 39 (SPG39) (upper motor neuron involvement, peripheral neuropathy, and sometimes reduced cognitive functioning and/or cerebellar ataxia)." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK247161/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/pnpla6-dis/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK247161/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CE4A0E0411AC1000000000035000F.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK247161_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK247161_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cdg-1a/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/alpers/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK247161_"><span class="title" itemprop="name"><i>PNPLA6-</i>Related Disorders</span></h1><p class="contrib-group"><span itemprop="author">Matthis Synofzik</span>, MD, <span itemprop="author">Robert B Hufnagel</span>, MD, PhD, and <span itemprop="author">Stephan Z&#x000fc;chner</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK247161_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK247161_ai__"><div class="contrib half_rhythm"><span itemprop="author">Matthis Synofzik</span>, MD<div class="affiliation small">Department of Neurodegenerative Diseases<br />Hertie Institute for Clinical Brain Research<br />University of T&#x000fc;bingen<br />T&#x000fc;bingen, Germany<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.negnibeut-inu@kizfonys.sihttam" class="oemail">ed.negnibeut-inu@kizfonys.sihttam</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Robert B Hufnagel</span>, MD, PhD<div class="affiliation small">Division of Human Genetics<br />Cincinnati Children's Hospital Medical Center<br />Cincinnati, Ohio<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cmhcc@leganfuh.trebor" class="oemail">gro.cmhcc@leganfuh.trebor</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Stephan Z&#x000fc;chner</span>, MD, PhD<div class="affiliation small">Dr John T Macdonald Foundation Department of Human Genetics<br />John P Hussman Institute for Human Genomics<br />University of Miami Miller School of Medicine<br />Miami, Forida<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.imaim.dem@renhcuzs" class="oemail">ude.imaim.dem@renhcuzs</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 9, 2014</span>; Last Update: <span itemprop="dateModified">June 11, 2015</span>.</p><p><em>Estimated reading time: 22 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="pnpla6-dis.Summary" itemprop="description"><h2 id="_pnpla6-dis_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>PNPLA6</i>-related disorders span a phenotypic continuum characterized by variable combinations of cerebellar ataxia, upper motor neuron involvement manifesting as spasticity and/or brisk reflexes, chorioretinal dystrophy associated with variable degrees of reduced visual function, and hypogonadotropic hypogonadism (delayed puberty and lack of secondary sex characteristics), either in isolation or as part of anterior hypopituitarism (growth hormone, thyroid hormone, or gonadotropin deficiencies). Common but less frequent features are peripheral neuropathy (usually of axonal type manifesting as reduced distal reflexes, diminished vibratory sensation, and/or distal muscle wasting), hair anomalies (long eyelashes, bushy eyebrows, or scalp alopecia), short stature, and impaired cognitive functioning (learning disabilities in children and deficits in attention, visuospatial abilities, and recall in adults). Some of these features can occur in distinct clusters on the phenotypic continuum: Boucher-Neuh&#x000e4;user syndrome (cerebellar ataxia, chorioretinal dystrophy, and hypogonadotropic hypogonadism); Gordon Holmes syndrome (cerebellar ataxia, hypogonadotropic hypogonadism, and &#x02013; to a variable degree &#x02013; brisk reflexes); Oliver-McFarlane syndrome (trichomegaly, chorioretinal dystrophy, short stature, intellectual disability, and hypopituitarism); Laurence-Moon syndrome; and spastic paraplegia type 39 (SPG39) (upper motor neuron involvement, peripheral neuropathy, and sometimes reduced cognitive functioning and/or cerebellar ataxia).</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of a <i>PNPLA6-</i>related disorder is suspected on clinical and neuroimaging findings and confirmed by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>PNPLA6.</i></p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Management is symptomatic and individually tailored.</p><ul><li class="half_rhythm"><div>Ataxia: continuous training of speech and swallowing, fine-motor skills, gait, and balance</div></li><li class="half_rhythm"><div>Spasticity: interventions to improving strength and agility such as exercises, assistive walking devices and/or ankle-foot orthotics, drugs to reduce muscle spasticity</div></li><li class="half_rhythm"><div>Chorioretinal dystrophy: low vision aids when central acuity is reduced; involvement with agencies for the visually impaired re vocational training, mobility training, and skills for independent living</div></li><li class="half_rhythm"><div>Hypothyroidism: hormone replacement therapy as soon as identified</div></li><li class="half_rhythm"><div>Growth hormone deficiency: hormone replacement therapy during childhood and/or adolescence as indicated</div></li><li class="half_rhythm"><div>Hypogonadotropic hypogonadism: hormone replacement therapy at the expected time of puberty</div></li></ul><p><i>Prevention of secondary complications:</i> A daily regimen of physical therapy to maintain and improve coordination, muscle strength, and gait; to reduce spasticity; and to prevent contractures.</p><p><i>Surveillance:</i> Periodic evaluations (annually or as needed) by a neurologist, ophthalmologist and (if necessary) an endocrinologist to assess progression and develop treatment strategies.</p><p><i>Agents/circumstances to avoid:</i> Alcohol; obesity; inactive, sedentary lifestyle; exposure to medications or chemicals that exacerbate neuropathy.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>PNPLA6</i>-related disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the <i>PNPLA6</i> pathogenic variants in the family have been identified.</p></div></div><div id="pnpla6-dis.GeneReview_Scope"><h2 id="_pnpla6-dis_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="pnpla6-dis.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK247161/table/pnpla6-dis.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pnpla6-dis.Tc_lrgtbl__"><table><thead><tr><th id="hd_h_pnpla6-dis.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>PNPLA6</i>-Related Disorders: Included Phenotypes</th></tr></thead><tbody><tr><td headers="hd_h_pnpla6-dis.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Boucher-Neuh&#x000e4;user syndrome</div></li><li class="half_rhythm"><div><i>PNPLA6</i>-related Gordon Holmes syndrome</div></li><li class="half_rhythm"><div>Oliver-McFarlane syndrome</div></li><li class="half_rhythm"><div><i>PNPLA6</i>-related Laurence-Moon syndrome</div></li><li class="half_rhythm"><div>Spastic paraplegia type 39 (SPG39)</div></li></ul></td></tr></tbody></table></div></div></div><div id="pnpla6-dis.Diagnosis"><h2 id="_pnpla6-dis_Diagnosis_">Diagnosis</h2><p>Due to its highly heterogeneous nature, no formal diagnostic criteria have been established for <i>PNPLA6</i>-related disorders based on clinical findings alone. The diagnosis can only be established by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p><div id="pnpla6-dis.Suggestive_Findings"><h3>Suggestive Findings</h3><p>A <i>PNPLA6-</i>related disorder should be suspected in individuals with a combination of two or more of the following clinical features:</p><ul><li class="half_rhythm"><div><b>Cerebellar ataxia</b> starting before age 50 years and associated with cerebellar atrophy</div></li><li class="half_rhythm"><div><b>Upper motor neuron involvement</b> presenting as spasticity and/or brisk reflexes</div></li><li class="half_rhythm"><div><b>Chorioretinal dystrophy</b> starting before age 50 years and leading to variable degrees of reduced visual function, including blindness. The diagnosis of chorioretinal dystrophy may be established by ophthalmologic assessment, including visual acuity, visual field testing, fundoscopy, and optic coherence tomography (OCT) [<a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2015.580">Synofzik et al 2015</a>]. OCT can detect thinning of the retina, loss of layered retinal architecture, and effacement of the choriocapillaris and choroidal vessels. Autofluorescence photographs and fluorescein angiography provide supplementary diagnostic information by revealing hyper- and hypofluorescent regions of abnormal retinal pigment epithelium and the choriocapillaris.</div></li><li class="half_rhythm"><div><b>Hypogonadotropic hypogonadism</b> usually presenting in the first two decades of life</div></li></ul><p>Common, but less frequent features:</p><ul><li class="half_rhythm"><div><b>Anterior hypopituitarism.</b> Deficiency of hormones made by the anterior pituitary can result in growth hormone deficiency and insufficient production of thyroid or sex hormones. Deficient thyroid hormone production can result in intellectual disability in infancy and childhood and poor growth in infancy, childhood, and adolescence. Growth hormone deficiency can lead to short stature in infancy, childhood, or adolescence. Insufficient sex hormone production can lead to hypogonadotropic hypogonadism (see above).</div></li><li class="half_rhythm"><div><b>Peripheral neuropathy</b> (usually of axonal type), presenting with reduced distal reflexes, diminished vibratory sensation, and/or distal muscle wasting</div></li><li class="half_rhythm"><div><b>Impaired</b>
<b>cognitive functioning</b> unrelated to hormone deficiency that can include learning disabilities in children [<a class="bk_pop" href="#pnpla6-dis.REF.yoon.2013.181">Yoon et al 2013</a>] and deficits in attention, visuospatial abilities, and recall in adults</div></li><li class="half_rhythm"><div><b>Hair anomalies</b> (long eyelashes, bushy eyebrows, or scalp alopecia)</div></li></ul><p>Some of these features can occur in certain combinations, presenting in partly distinct/partly overlapping clusters on the phenotypic continuum of the <i>PNPLA6-</i>related disorders:</p><ul><li class="half_rhythm"><div><b>Boucher-Neuh&#x000e4;user syndrome.</b> Cerebellar ataxia, chorioretinal dystrophy, and hypogonadotropic hypogonadism [<a class="bk_pop" href="#pnpla6-dis.REF.boucher.1969.507">Boucher &#x00026; Gibberd 1969</a>]; high predictive value (75%) for an underlying <i>PNPLA6</i>-related disorder [<a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</a>, <a class="bk_pop" href="#pnpla6-dis.REF.tarnutzer.2015.194">Tarnutzer et al 2015</a>]</div></li><li class="half_rhythm"><div><b>Gordon Holmes syndrome.</b> Cerebellar ataxia, hypogonadotropic hypogonadism, and (to a variable degree) brisk reflexes [<a class="bk_pop" href="#pnpla6-dis.REF.holmes.1907.466">Holmes 1907</a>]</div></li><li class="half_rhythm"><div><b>Oliver-McFarlane syndrome.</b> Trichomegaly, chorioretinal dystrophy, and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> or childhood hypopituitarism [<a class="bk_pop" href="#pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</a>, <a class="bk_pop" href="#pnpla6-dis.REF.kmoch.2015.5614">Kmoch et al 2015</a>]</div></li><li class="half_rhythm"><div><b>Laurence-Moon syndrome.</b> Cerebellar ataxia, chorioretinal dystrophy, peripheral neuropathy, spastic paraplegia and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> or childhood hypopituitarism. One family diagnosed with Laurence-Moon syndrome has been reported to have <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>PNPLA6</i> [<a class="bk_pop" href="#pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</a>]. Several other people with the same phenotypic cluster and biallelic pathogenic variants in <i>PNPLA6</i> have been reported [<a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</a>] and described to have "spastic Boucher-Neuh&#x000e4;user syndrome," demonstrating the continuum of <i>PNPLA6</i>- associated phenotypic clusters.</div></li><li class="half_rhythm"><div><b>Spastic paraplegia type 39 (SPG39).</b> Upper motor neuron involvement and peripheral neuropathy, and sometimes reduced cognitive functioning and/or cerebellar ataxia [<a class="bk_pop" href="#pnpla6-dis.REF.rainier.2008.780">Rainier et al 2008</a>]</div></li><li class="half_rhythm"><div><b>Severe retinal dystrophy with atrophy</b> associated with autism, reported in one child with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>PNPLA6</i> [<a class="bk_pop" href="#pnpla6-dis.REF.kmoch.2015.5614">Kmoch et al 2015</a>]. The child had been previously given a diagnosis of Leber <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> amaurosis (LCA). Given the age of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, it is possible that further features of one of the above clinical diagnoses could develop with time. See <a href="/books/n/gene/lca-ov/">Leber Congenital Amaurosis / Early-Onset Severe Retinal Dystrophy Overview</a>.</div></li></ul><p>The full phenotypic spectrum of <i>PNPLA6</i>-related disorders and the predictive value of the clinical features for identifying an underlying <i>PNPLA6</i>-related disorder remain to be confirmed.</p></div><div id="pnpla6-dis.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of a <i>PNPLA6-</i>related disorder is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by detection of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>PNPLA6</i> pathogenic variants in <a class="def" href="/books/n/gene/glossary/def-item/trans/"><i>trans</i></a> configuration (see <a class="figpopup" href="/books/NBK247161/table/pnpla6-dis.T.molecular_genetic_testing_u/?report=objectonly" target="object" rid-figpopup="figpnpla6disTmoleculargenetictestingu" rid-ob="figobpnpla6disTmoleculargenetictestingu">Table 1</a>).</p><p><b>One genetic testing strategy</b> is <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>PNPLA6,</i> followed by <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified. One <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> duplication has been reported to date [<a class="bk_pop" href="#pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</a>].</p><p><b>An alternative genetic testing strategy</b> is use of a multigene sequencing panel that includes <i>PNPLA6</i> and other genes of interest (see <a href="#pnpla6-dis.Differential_Diagnosis">Differential Diagnosis</a>). Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><div id="pnpla6-dis.T.molecular_genetic_testing_u" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>PNPLA6-</i>Related Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK247161/table/pnpla6-dis.T.molecular_genetic_testing_u/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pnpla6-dis.T.molecular_genetic_testing_u_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_pnpla6-dis.T.molecular_genetic_testing_u_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_pnpla6-dis.T.molecular_genetic_testing_u_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_pnpla6-dis.T.molecular_genetic_testing_u_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_pnpla6-dis.T.molecular_genetic_testing_u_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>PNPLA6</i></td><td headers="hd_h_pnpla6-dis.T.molecular_genetic_testing_u_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>2</sup></td><td headers="hd_h_pnpla6-dis.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;20 families reported to date</td></tr><tr><td headers="hd_h_pnpla6-dis.T.molecular_genetic_testing_u_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_pnpla6-dis.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 reported to date&#x000a0;<sup>4</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="pnpla6-dis.TF.1.1"><p class="no_margin">See <a href="/books/NBK247161/#pnpla6-dis.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#pnpla6-dis.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>2. </dt><dd><div id="pnpla6-dis.TF.1.2"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>3. </dt><dd><div id="pnpla6-dis.TF.1.3"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>4. </dt><dd><div id="pnpla6-dis.TF.1.4"><p class="no_margin">An intragenic <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of exons 14-20 in <i>PNPLA6</i> has been reported in one individual with Oliver-McFarlane syndrome [<a class="bk_pop" href="#pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</a>].</p></div></dd></dl></div></div></div></div></div><div id="pnpla6-dis.Clinical_Characteristics"><h2 id="_pnpla6-dis_Clinical_Characteristics_">Clinical Characteristics</h2><div id="pnpla6-dis.Clinical_Description"><h3>Clinical Description</h3><p>In all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported to date, features of the <i>PNPLA6</i>-related disorder manifested in the first two decades of life [<a class="bk_pop" href="#pnpla6-dis.REF.rainier.2011.19">Rainier et al 2011</a>, <a class="bk_pop" href="#pnpla6-dis.REF.yoon.2013.181">Yoon et al 2013</a>, <a class="bk_pop" href="#pnpla6-dis.REF.deik.2014.2411">Deik et al 2014</a>, <a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</a>, <a class="bk_pop" href="#pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</a>, <a class="bk_pop" href="#pnpla6-dis.REF.kmoch.2015.5614">Kmoch et al 2015</a>, <a class="bk_pop" href="#pnpla6-dis.REF.tarnutzer.2015.194">Tarnutzer et al 2015</a>]. The initial findings include one or several of the following features: gait disturbance, visual impairment due to chorioretinal dystrophy or atrophy, anterior hypopituitarism, or delayed puberty/primary amenorrhea. Gait disturbance may precede visual impairment or anterior hypopituitarism; or, in contrast, gait disturbance may follow visual impairment or hypopituitarism up to 35 years later [<a class="bk_pop" href="#pnpla6-dis.REF.deik.2014.2411">Deik et al 2014</a>]. Although the combination of the three most common findings (gait disturbance, visual impairment, and delayed puberty/primary amenorrhea) is highly indicative of an underlying <i>PNPLA6</i>-related disorder, no single feature is specific or obligatory.</p><p>Given the limited number of individuals reported to date and the lack of longitudinal studies of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, a more detailed understanding of the natural history of <i>PNPLA6</i>-related disorders remains to be determined.</p><p>Gait disturbance is due to <b>ataxia, spasticity (with or without paresis), peripheral neuropathy</b>, or a combination thereof. Progression of the gait disturbance varies: more severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals lose the ability to walk without aid between ages 25 and 50 years and may become wheelchair dependent at this stage [<a class="bk_pop" href="#pnpla6-dis.REF.rainier.2011.19">Rainier et al 2011</a>, <a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</a>]; less affected individuals are still able to walk unaided at age 54 years [<a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</a>].</p><p><b>Peripheral</b>
<b>neuropathy</b>, if present, is usually of the axonal motor type, including an additional sensory component (sensorimotor neuropathy) reported to date in only three cases [Author, unpublished observation]. The motor neuropathy can be associated with severe atrophy of distal muscles, in particular the distal leg and intrinsic hand muscles, starting in the late teens [<a class="bk_pop" href="#pnpla6-dis.REF.rainier.2011.19">Rainier et al 2011</a>]. Impairment of the sensory tracts (peripheral sensory neurons, dorsal columns) including diminished vibration sense and touch has been reported in different age groups [<a class="bk_pop" href="#pnpla6-dis.REF.rainier.2011.19">Rainier et al 2011</a>, <a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</a>, <a class="bk_pop" href="#pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</a>, <a class="bk_pop" href="#pnpla6-dis.REF.kmoch.2015.5614">Kmoch et al 2015</a>].</p><p>Functional impairment due to <b>upper motor neuron involvement</b> varies: while some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals show only increased reflexes or extensor plantar responses, others have severe spastic paraparesis of the lower extremities [<a class="bk_pop" href="#pnpla6-dis.REF.rainier.2011.19">Rainier et al 2011</a>, <a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</a>, <a class="bk_pop" href="#pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</a>]. Electrophysiologic data available are currently insufficient to determine whether corticospinal tract involvement is axonal (with motor evoked potentials showing almost normal central motor conduction times) or demyelinating (with motor evoked potentials showing severely prolonged central motor conduction times).</p><p>Progressive <b>visual impairment</b>, which is less frequent than gait disturbances in the <i>PNPLA6</i>-related disorders, is typically due to chorioretinal dystrophy that is usually characterized by diffuse atrophy of choroidal vessels and retinal pigment epithelium on fundoscopy, leading to complete loss of the choriocapillaris layer and the retinal pigment epithelium [<a class="bk_pop" href="#pnpla6-dis.REF.deik.2014.2411">Deik et al 2014</a>, <a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2015.580">Synofzik et al 2015</a>], including death of photoreceptors and retinal thinning accompanied by lipofuscin metabolism abnormalities [<a class="bk_pop" href="#pnpla6-dis.REF.kmoch.2015.5614">Kmoch et al 2015</a>]. Initially these deficits can present in the first few years of life with nystagmus, choroidal and retinal pigment atrophy, and bitemporal central visual field defects and blind spot enlargement. Visual acuity is often severely reduced (to perception of hand motion) such that some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals meet the criteria for legal blindness in adolescence or adulthood [<a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</a>, <a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2015.580">Synofzik et al 2015</a>, <a class="bk_pop" href="#pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</a>, <a class="bk_pop" href="#pnpla6-dis.REF.kmoch.2015.5614">Kmoch et al 2015</a>].</p><p><b>Anterior hypopituitarism</b> manifests either in infancy or childhood (micropenis, cryptorchidism, thyroid and growth hormone deficiency) or in adolescence (hypogonadotropic hypogonadism and growth hormone deficiency) [<a class="bk_pop" href="#pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</a>]. Congenital hypothyroidism and growth hormone deficiency can result in global developmental delay, severe cognitive impairment, and short stature. Hypogonadotropic hypogonadism usually becomes manifest during the second decade of life with delayed puberty and lack of secondary sexual characteristics including primary amenorrhea, small penis and testes, and absent pubic hair and/or breast development. These hormone deficiencies are responsive to hormone replacement therapy.</p><p><b>Cognitive functioning</b> appears to be impaired in many (albeit not all) individuals with a <i>PNPLA6</i>-related disorder, including learning disabilities in children [<a class="bk_pop" href="#pnpla6-dis.REF.yoon.2013.181">Yoon et al 2013</a>] and deficits in attention, visuospatial abilities, and recall in adults. Cognitive disability may be related to hypothyroidism in certain but not all individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>PNPLA6</i>.</p><p><b>Neuroimaging</b> has shown the following:</p><ul><li class="half_rhythm"><div>Cerebellar atrophy in approximately 90% of all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#pnpla6-dis.REF.rainier.2011.19">Rainier et al 2011</a>, <a class="bk_pop" href="#pnpla6-dis.REF.yoon.2013.181">Yoon et al 2013</a>, <a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</a>]</div></li><li class="half_rhythm"><div>Small pituitary in 20%-30% of all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#pnpla6-dis.REF.yoon.2013.181">Yoon et al 2013</a>, <a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</a>, <a class="bk_pop" href="#pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</a>]</div></li><li class="half_rhythm"><div>Thoracic cord atrophy in one individual [<a class="bk_pop" href="#pnpla6-dis.REF.rainier.2011.19">Rainier et al 2011</a>]</div></li></ul></div><div id="pnpla6-dis.GenotypePhenotype_Correlation"><h3>Genotype-Phenotype Correlations</h3><p>No obvious <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation exists. It has been suggested that different <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants could lead to different dose-dependent reductions in hydrolysis activity of the neuropathy target esterase (NTE), with more severe reductions leading to more severe and early-onset phenotypes [<a class="bk_pop" href="#pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</a>]. However, this hypothesis warrants further confirmation from larger genotype-phenotype studies, in particular given the fact that the same <i>PNPLA6</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> can lead to different presentations (e.g., ataxia plus hypogonadism in one individual, and spastic ataxia in another) and to different degrees and progression rates of manifestation (e.g., loss of ambulation in a 44-year-old with a 17-year history of ataxia vs. full ambulation in a 42-year-old with a 36-year history of ataxia) [<a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</a>]. Correspondingly, manifestations and disease progression differ not only between but also within families.</p><p>Nor does the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> appear to depend on either the location of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (e.g., mutation of the functionally important phospholipid esterase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> can present with a severe Oliver-McFarlane or Boucher-Neuh&#x000e4;user syndrome as well as with relatively mild spastic paraplegia; pathogenic variants occurring outside the esterase domain have been associated with Boucher-Neuh&#x000e4;user syndrome, Oliver-McFarlane syndrome, and severe retinal dystrophy with atrophy and autism) or the pathogenic variant type (e.g., both <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and frameshift variants have been reported with severe Oliver-McFarlane or Boucher-Neuh&#x000e4;user syndrome as well as with mild spastic ataxia) [<a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</a>, <a class="bk_pop" href="#pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</a>, <a class="bk_pop" href="#pnpla6-dis.REF.kmoch.2015.5614">Kmoch et al 2015</a>].</p></div><div id="pnpla6-dis.Penetrance"><h3>Penetrance</h3><p>Penetrance appears to be complete in individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>PNPLA6</i> pathogenic variants.</p></div><div id="pnpla6-dis.Prevalence"><h3>Prevalence</h3><p><i>PNPLA6</i>-related disorders are rare in unselected neurologic populations. <a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al [2014a]</a> identified two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> persons in 538 unrelated individuals with ataxia, spastic paraplegia, and/or neuropathy.</p><p>In contrast, mutation of <i>PNPLA6</i> is common in Boucher-Neuh&#x000e4;user syndrome and Oliver-McFarlane syndrome: individuals in four of six families with Boucher-Neuh&#x000e4;user syndrome and 11 of 12 families with Oliver-McFarlane syndrome had <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>PNPLA6</i> [<a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</a>, <a class="bk_pop" href="#pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</a>, <a class="bk_pop" href="#pnpla6-dis.REF.kmoch.2015.5614">Kmoch et al 2015</a>]. Given that clinical descriptions of more than 30 index cases with Boucher-Neuh&#x000e4;user or Oliver-McFarlane syndromes have been reported to date, the number of individuals with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> who are found to have biallelic <i>PNPLA6</i> pathogenic variants is likely to increase soon.</p></div></div><div id="pnpla6-dis.Genetically_Related_Allelic_D"><h2 id="_pnpla6-dis_Genetically_Related_Allelic_D_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with mutation of <i>PNPLA6</i>.</p></div><div id="pnpla6-dis.Differential_Diagnosis"><h2 id="_pnpla6-dis_Differential_Diagnosis_">Differential Diagnosis</h2><div id="pnpla6-dis.Disorders_with_Ataxia"><h3>Disorders with Ataxia</h3><p><b>Ataxia with hypogonadism and dementia.</b> In contrast to <i>RNF216/OTUD4</i>-associated ataxia-hypogonadism, <i>PNPLA6</i>-related disorders are not typically accompanied by dementia. Biallelic mutation of <i>RNF216</i> or, in one family, <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in both <i>RNF216</i> and <i>OTUD4</i>, are causative [<a class="bk_pop" href="#pnpla6-dis.REF.margolin.2013.1992">Margolin et al 2013</a>].</p><p><b>Autosomal recessive spinocerebellar ataxia 16</b>
<b>(SCAR16)</b> is characterized by ataxia with cerebellar atrophy and, to a variable degree, cognitive impairment, hypogonadism, and/or pyramidal tract involvement [<a class="bk_pop" href="#pnpla6-dis.REF.shi.2014.1013">Shi et al 2014</a>, <a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2014b.57">Synofzik et al 2014b</a>]. While phenotypic overlap exists, <i>PNPLA6</i>-related disorders are characterized by more rapid disease progression, and (unlike SCAR16), they include chorioretinal dystrophy. Biallelic pathogenic variants in <i>STUB1</i> (<i>CHIP</i>) are causative. See <a href="/books/n/gene/ataxias/">Hereditary Ataxia Overview</a>.</p><p><a href="/books/n/gene/pol3-leuk/"><b>Ataxia with hypogonadotropic hypogonadism, dental abnormalities and hypomyelinating leukodystrophy</b></a><b>.</b> In contrast to this disorder, <i>PNPLA6</i>-related disorders are not associated with dental abnormalities or leukodystrophy. Biallelic pathogenic variants in <i>POLR3A</i> or <i>POLR3B</i> are causative [<a class="bk_pop" href="#pnpla6-dis.REF.daoud.2013.194">Daoud et al 2013</a>, <a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2013a.e145">Synofzik et al 2013a</a>].</p><p><a href="/books/n/gene/mss/"><b>Marinesco-Sj&#x000f6;gren syndrome</b></a> is characterized by cerebellar ataxia with cerebellar atrophy, early-onset cataracts, mild to severe intellectual disability, hypotonia, muscle weakness, and hypergonadotropic hypogonadism due to <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SIL1</i>. Marinesco-Sj&#x000f6;gren syndrome is invariably associated with the combination of a cerebellar syndrome, chronic myopathy, and cataracts after age seven years [<a class="bk_pop" href="#pnpla6-dis.REF.krieger.2013.3634">Krieger et al 2013</a>]; myopathy and cataracts have not been reported in <i>PNPLA6</i>-related disorders. Biallelic mutation of <i>SIL1</i> is causative.</p><p><b>Ataxia with hypergonadotropic hypogonadism due to coenzyme Q<sub>10</sub> deficiency.</b> In contrast to coenzyme Q<sub>10</sub> deficiency, <i>PNPLA6</i>-related disorders may present with hypogonadotropic hypogonadism, and are not known to be associated with CoQ<sub>10</sub> deficiency. See <a href="/books/n/gene/ataxias/">Hereditary Ataxia Overview</a>.</p><p><a href="/books/n/gene/sca-io/"><b>Infantile-onset spinocerebellar ataxia</b></a>
<b>(IOSCA)</b> is a severe, progressive neurodegenerative disorder characterized by normal development until age one year, followed by onset of ataxia, muscle hypotonia, loss of deep-tendon reflexes, and athetosis. By adolescence, hypergonadotropic hypogonadism in females becomes evident. In contrast to <i>PNPLA6</i>-related disorders, IOSCA usually starts in early childhood and is mostly accompanied by athetosis, deafness, ophthalmoplegia, and/or epilepsy. Biallelic pathogenic variants in <i>TWNK</i> (previously <i>C10orf2</i>) are causative.</p><p><a href="/books/n/gene/ab-lipo-p/"><b>Abetalipoproteinemia</b></a>
<b>(Bassen-Kornzweig syndrome)</b> and <b><a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a></b>
<b>hypobetalipoproteinemia</b> (OMIM <a href="http://omim.org/entry/615558" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615558</a>, <a href="http://omim.org/entry/605019" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">605019</a>) present with retinitis pigmentosa, progressive ataxia, steatorrhea, demyelinating neuropathy, dystonia, extrapyramidal signs, and spastic paraparesis (rare). Hypocholesterolemia and reduced lipid-soluble vitamins in serum are due to defective intestinal absorption of lipids. Biallelic pathogenic variants in <i>MTP</i> are causative of abetalipoproteinemia. Mutation of <i>APOB</i> or <i>ANGPTL3</i> causes familial hypobetalipoproteinemia.</p><p><a href="/books/n/gene/narp/"><b>Neurogenic muscle weakness, ataxia, and retinitis pigmentosa</b></a> (NARP) is a childhood-onset disease most often characterized by proximal neurogenic muscle weakness with sensory neuropathy, ataxia, learning difficulties, and pigmentary retinopathy. Mutation of the mitochondrial DNA <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <i>MT-ATP6</i> is causative.</p><p><a href="/books/n/gene/refsum/"><b>Refsum disease</b></a> is characterized by anosmia (a universal finding) and early-onset retinitis pigmentosa with variable combinations of chronic polyneuropathy, deafness, cerebellar ataxia, and ichthyosis. Cardiac conduction disorders are common. Serum concentration of phytanic acids is increased as their degradation is impeded by the underlying genetic defect. Biallelic pathogenic variants in <i>PHYH</i> or <i>PEX7</i> are causative.</p><p><a href="/books/n/gene/sca7/"><b>Spinocerebellar ataxia type 7</b></a> is characterized by progressive cerebellar ataxia, including dysarthria and dysphagia, and a cone-rod retinal dystrophy with progressive central visual loss resulting in blindness in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> adults. Onset in early childhood or infancy has an especially rapid and aggressive course often associated with failure to thrive and regression of motor milestones. Expansion of a CAG <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> in <i>ATXN7</i> is causative.</p><p><a href="/books/n/gene/aved/"><b>Ataxia with vitamin E deficiency</b></a>
<b>(AVED)</b> presents with early-onset progressive ataxia, clumsiness of the hands, loss of proprioception (especially of vibration and joint position sense), and areflexia. The principal criterion for diagnosis of AVED is a Friedreich ataxia-like neurologic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> combined with markedly reduced plasma vitamin E (&#x003b1;-tocopherol) concentration in the absence of known causes of malabsorption. Biallelic pathogenic variants in <i>TTPA</i> are causative.</p><p><a href="/books/n/gene/spg20/"><b>Troyer syndrome</b></a> is characterized by progressive spastic paraparesis, dysarthria, pseudobulbar palsy, distal amyotrophy, motor and cognitive delays, short stature, and subtle skeletal abnormalities. Biallelic pathogenic variants in <i>SPART</i> are causative.</p><p>See also <a href="/books/n/gene/ataxias/">Hereditary Ataxia Overview</a>.</p></div><div id="pnpla6-dis.Chorioretinal_Dystrophy"><h3>Chorioretinal Dystrophy</h3><p><a href="/books/n/gene/lca-ov/"><b>Leber congenital amaurosis</b></a>
<b>(LCA),</b> a severe dystrophy of the retina, typically becomes evident in the first year of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia, and keratoconus. Visual acuity is rarely better than 20/400. A characteristic finding is Franceschetti's oculo-digital sign, comprising eye poking, pressing, and rubbing. The appearance of the fundus is extremely variable. While the retina may initially appear normal, a pigmentary retinopathy reminiscent of retinitis pigmentosa is frequently observed later in childhood. The electroretinogram (ERG) is characteristically "nondetectable" or severely subnormal. Pathogenic variants in 17 genes are known to cause LCA: <i>GUCY2D</i> (<a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a>: LCA1), <i>RPE65</i> (LCA2), <i>SPATA7</i> (LCA3), <i>AIPL1</i> (LCA4), <i>LCA5</i> (LCA5), <i>RPGRIP1</i> (LCA6), <i>CRX</i> (LCA7), <i>CRB1</i> (LCA8), <i>NMNAT1</i> (LCA9), <i>CEP290</i> (LCA10), <i>IMPDH1</i> (LCA11), <i>RD3</i> (LCA12), <i>RDH12</i> (LCA13), <i>LRAT</i> (LCA14)<i>, TULP1</i> (LCA15)<i>, KCNJ13</i> (LCA16), and <i>IQCB1</i>. Together, pathogenic variants in these genes are estimated to account for more than half of all LCA diagnoses. LCA is most often inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner, with the exception of LCA caused by <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>CRX</i>, which is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p><p>See also <a href="/books/n/gene/rp-overview/">Retinitis Pigmentosa Overview</a>.</p></div><div id="pnpla6-dis.Other_Types_of_Disorders"><h3>Other Types of Disorders</h3><p><b>Multisystem mitochondrial diseases</b> with retinopathy. See <a href="/books/n/gene/mt-overview/">Mitochondrial Disorders Overview</a>.</p><p><b>Peripheral neuropathies</b> with additional multisystem disease, including retinopathies. See <a href="/books/n/gene/cmt/">Charcot-Marie-Tooth Hereditary Neuropathy Overview</a>.</p><p><b>Complicated hereditary spastic paraplegias.</b> See <a href="/books/n/gene/hsp/">Hereditary Spastic Paraplegia Overview</a>.</p></div></div><div id="pnpla6-dis.Management"><h2 id="_pnpla6-dis_Management_">Management</h2><div id="pnpla6-dis.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with a <i>PNPLA6</i>-related disorder, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>MRI of the cerebrum (including the pituitary), cerebellum, and spinal cord (including the thoracic cord) to establish the extent of atrophy in the different brain regions and exclude other secondary causes for the clinical features</div></li><li class="half_rhythm"><div>Nerve conduction studies and EMG to determine the presence and extent of peripheral neuropathy</div></li><li class="half_rhythm"><div>Neuropsychological investigation, including IQ, attention span, visuospatial abilities, and recall</div></li><li class="half_rhythm"><div>If not performed at the time of diagnosis, ophthalmologic assessment, including visual acuity, visual field testing, fundoscopy, and optic coherence tomography (OCT) [<a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2015.580">Synofzik et al 2015</a>]. OCT can detect thinning of the retina, loss of layered retinal architecture, and effacement of the choriocapillaris and choroidal vessels. Autofluorescence photographs and fluorescein angiography provide supplementary diagnostic information by revealing hyper- and hypofluorescent regions of abnormal retinal pigment epithelium and the choriocapillaris.</div></li><li class="half_rhythm"><div>If not performed at the time of diagnosis, endocrinologic assessment for evidence of hypothyroidism, growth hormone deficiency, and hypogonadotropic hypogonadism. Hypogonadotropic hypogonadism is detected by decreased rise of gonadotropin levels (LH, FSH) in response to gonadotropin releasing hormone (GnRH). (See <a href="/books/n/gene/kms/">Isolated Gonadotropin-Releasing Hormone Deficiency</a> for more details about evaluation.)</div></li><li class="half_rhythm"><div>Clinical genetics consultation</div></li></ul></div><div id="pnpla6-dis.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>No disease-modifying drug treatment exists for <i>PNPLA6</i>-related disorders. Given the great phenotypic variability and broad spectrum of the disorders, management of symptoms must be individually tailored.</p><p><b>Ataxia.</b> Management should be directed to providing continuous training in the form of active speech, fine-motor, and gait exercises [<a class="bk_pop" href="#pnpla6-dis.REF.fonteyn.2014.251">Fonteyn et al 2014</a>, <a class="bk_pop" href="#pnpla6-dis.REF.ilg.2014.248">Ilg et al 2014</a>, <a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2014.583507">Synofzik &#x00026; Ilg 2014</a>]:</p><ul><li class="half_rhythm"><div>Daily regimen with physiotherapy exercises focusing on active, physically demanding tasks [<a class="bk_pop" href="#pnpla6-dis.REF.ilg.2009.1823">Ilg et al 2009</a>, <a class="bk_pop" href="#pnpla6-dis.REF.ilg.2010.2239">Ilg et al 2010</a>]</div></li><li class="half_rhythm"><div>Videogame-based whole-body training ("exergames") with specific videogames aiming to improve coordination and rapid adaptation to changing environments [<a class="bk_pop" href="#pnpla6-dis.REF.ilg.2012.2056">Ilg et al 2012</a>, <a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2013b.2656">Synofzik et al 2013b</a>]</div></li><li class="half_rhythm"><div>Speech therapy [<a class="bk_pop" href="#pnpla6-dis.REF.sapir.2003.387">Sapir et al 2003</a>]</div></li><li class="half_rhythm"><div>Swallowing therapy</div></li></ul><p><b>Spasticity.</b> Management should be directed to improving balance, strength, and agility:</p><ul><li class="half_rhythm"><div>Daily regimen with physiotherapy exercises focusing on improving muscle strength and gait and reducing spasticity</div></li><li class="half_rhythm"><div>Assistive walking devices and ankle-foot orthotics</div></li><li class="half_rhythm"><div>Drugs to reduce muscle spasticity (e.g., baclofen [oral or intrathecal], tolperison; Botox<sup>&#x000ae;</sup> injections) and urinary urgency (e.g., oxybutynin)</div></li></ul><p><b>Visual impairment.</b> Low vision aids such as magnifiers may facilitate reading for individuals with reduced central acuity.</p><p>In the US, publicly funded agencies for the visually impaired at the state level provide services for the blind or those with progressive eye disorders; services include vocational training, mobility training, and skills for independent living.</p><p><b>Hypothyroidism.</b> Hypothyroidism is treated with thyroid hormone replacement (e.g., levothyroxine) at the time of diagnosis. Thyroid hormone levels should be normalized by replacement therapy and monitored by an endocrinologist.</p><p><b>Growth hormone deficiency.</b> Growth hormone deficiency is treated with hormone replacement therapy and monitored by an endocrinologist.</p><p><b>Hypogonadism.</b> Hypogonadotropic hypogonadism is treated with hormone replacement therapy, often including gonadotropins, at the expected time of puberty. (See <a href="/books/n/gene/kms/">Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency</a>) for more details about treatment.)</p></div><div id="pnpla6-dis.Prevention_of_Secondary_Compl"><h3>Prevention of Secondary Complications</h3><p>Daily physical therapy is recommended to maintain and improve coordination, muscle strength, and gait; reduce spasticity; and prevent contractures.</p></div><div id="pnpla6-dis.Surveillance"><h3>Surveillance</h3><p>Patients should be evaluated periodically (annually or as needed) by a neurologist, ophthalmologist and, if necessary, endocrinologist to assess progression and develop treatment strategies.</p></div><div id="pnpla6-dis.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Avoid the following:</p><ul><li class="half_rhythm"><div>Alcohol</div></li><li class="half_rhythm"><div>Obesity</div></li><li class="half_rhythm"><div>Inactive, sedentary lifestyle</div></li><li class="half_rhythm"><div>Exposure to medications or chemicals that exacerbate neuropathy. See the Charcot-Marie-Tooth Association <a href="https://www.cmtausa.org/living-with-cmt/managing-cmt/medications/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">website</a> (pdf) for an up-to-date list of medications that are potentially toxic to persons with CMT or a related neuropathy.</div></li></ul></div><div id="pnpla6-dis.Evaluation_of_Relatives_at_Ri"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#pnpla6-dis.Related_Genetic_Counseling_Is">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="pnpla6-dis.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Anecdotally, ataxia may sometimes appear for the first time or worsen during pregnancy. Note: While some individuals with ataxia report a worsening of coordination after general anesthesia, no increased risk has been reported specifically with obstetric anesthesia.</p><p>Spasticity generally does not change significantly with pregnancy.</p></div><div id="pnpla6-dis.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="pnpla6-dis.Genetic_Counseling"><h2 id="_pnpla6-dis_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="pnpla6-dis.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>PNPLA6</i>-related disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="pnpla6-dis.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <i>PNPLA6</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Although <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sibs usually share most of the same <i>PNPLA6</i>-related phenotypic features, some features may be missing or additionally present. For example, within the same family, one sib may have all features of Boucher-Neuh&#x000e4;user syndrome and another sib may have either spastic ataxia with hypogonadism or chorioretinal dystrophy, but not both. The degree and progression of impairment may also differ between sibs.</div></li><li class="half_rhythm"><div>Once an at-risk sib is known to be unaffected, the risk of his/her being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> is 2/3.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with a <i>PNPLA6</i>-related disorder are obligate heterozygotes (carriers of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PNPLA6</i>).</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>&#x02019;s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</p></div><div id="pnpla6-dis.Heterozygote_Carrier_Detectio"><h3>Heterozygote (Carrier) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>PNPLA6</i> pathogenic variants in the family.</p></div><div id="pnpla6-dis.Related_Genetic_Counseling_Is"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="pnpla6-dis.Prenatal_Testing_and_Preimpla"><h3>Prenatal Testing and Preimplantation Genetic Testing</h3><p>Once the <i>PNPLA6</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> for a <i>PNPLA6</i>-related disorder are possible. However, given the possibility of <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a>, the results of such testing do not necessarily predict the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, age of onset, and/or severity of findings.</p><p>Prenatal testing requests vary in frequency for conditions which (like <i>PNPLA6</i>-related disorders) have no disease-modifying treatment and can present with a wide spectrum of phenotypic features. Requests may be more common in families in which <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have had early-onset disease affecting many neurologic systems as well as intellect. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="pnpla6-dis.Resources"><h2 id="_pnpla6-dis_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Ataxia UK</b></div><div>Lincoln House</div><div>1-3 Brixton Road</div><div>London SW9 6DE</div><div>United Kingdom</div><div><b>Phone:</b> 0845 644 0606 (helpline); 020 7582 1444 (office); +44 (0) 20 7582 1444 (from abroad)</div><div><b>Email:</b> helpline@ataxia.org.uk; office@ataxia.org.uk</div><div><a href="http://www.ataxia.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org.uk</a></div></li><li class="half_rhythm"><div><b>National Ataxia Foundation</b></div><div>2600 Fernbrook Lane</div><div>Suite 119</div><div>Minneapolis MN 55447</div><div><b>Phone:</b> 763-553-0020</div><div><b>Email:</b> naf@ataxia.org</div><div><a href="http://www.ataxia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Hereditary-Spastic-Paraplegia-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hereditary Spastic Paraplegia Information Page</a></div></li><li class="half_rhythm"><div><b>Spastic Paraplegia Foundation, Inc.</b></div><div>7700 Leesburg Pike</div><div>Ste 123</div><div>Falls Church VA 22043</div><div><b>Phone:</b> 877-773-4483 (toll-free)</div><div><b>Email:</b> information@sp-foundation.org</div><div><a href="http://sp-foundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">sp-foundation.org</a></div></li></ul></div><div id="pnpla6-dis.Molecular_Genetics"><h2 id="_pnpla6-dis_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="pnpla6-dis.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>PNPLA6-Related Disorders: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK247161/table/pnpla6-dis.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pnpla6-dis.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_pnpla6-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_pnpla6-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_pnpla6-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_pnpla6-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_pnpla6-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_pnpla6-dis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_pnpla6-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/10908" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PNPLA6</i></a></td><td headers="hd_b_pnpla6-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=10908" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">19p13<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_pnpla6-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q8IY17" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Neuropathy target esterase</a></td><td headers="hd_b_pnpla6-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://proteomics.bio21.unimelb.edu.au/lovd/genes/PNPLA6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PNPLA6 database</a></td><td headers="hd_b_pnpla6-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PNPLA6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PNPLA6</a></td><td headers="hd_b_pnpla6-dis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PNPLA6[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PNPLA6</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="pnpla6-dis.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="pnpla6-dis.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for PNPLA6-Related Disorders (<a href="/omim/212840,215470,245800,275400,603197,612020" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK247161/table/pnpla6-dis.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pnpla6-dis.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/212840" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">212840</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GORDON HOLMES SYNDROME; GDHS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/215470" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">215470</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">BOUCHER-NEUHAUSER SYNDROME; BNHS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/245800" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">245800</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LAURENCE-MOON SYNDROME; LNMS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/275400" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">275400</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">OLIVER-MCFARLANE SYNDROME; OMCS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603197" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603197</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 6; PNPLA6</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/612020" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">612020</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>PNPLA6</i> comprises 34 exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK247161/#pnpla6-dis.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The large majority of <i>PNPLA6</i> pathogenic variants identified to date cluster within a short stretch of about 300 nucleotides that encode the roughly 100 residues in the functionally critical EST <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> [<a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</a>].</p><p>Several reported <i>PNPLA6</i> pathogenic variants are located in the region encoding the CNB1 and CNB2 domains (e.g., c.787G&#x0003e;A and c.1732G&#x0003e;T). These and other variants in the CNB domains likely compromise the ability of one or both regulatory CNB1/2 domains to bind cyclic nucleotide-monophosphate binding domains (cNMPs); thus, their failure to undergo a conformational change in response to changes in intracellular concentration of cNMPs would keep the esterase (EST) <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> in an auto-inhibited state [<a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</a>, <a class="bk_pop" href="#pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</a>, <a class="bk_pop" href="#pnpla6-dis.REF.kmoch.2015.5614">Kmoch et al 2015</a>].</p><div id="pnpla6-dis.T.pnpla6_pathogenic_variants" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>PNPLA6</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK247161/table/pnpla6-dis.T.pnpla6_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pnpla6-dis.T.pnpla6_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_pnpla6-dis.T.pnpla6_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_pnpla6-dis.T.pnpla6_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_pnpla6-dis.T.pnpla6_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_pnpla6-dis.T.pnpla6_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.787G&#x0003e;A</td><td headers="hd_h_pnpla6-dis.T.pnpla6_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val263Ile</td><td headers="hd_h_pnpla6-dis.T.pnpla6_pathogenic_variants_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_001166111.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001166111<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/protein/NP_001159583.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001159583<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_pnpla6-dis.T.pnpla6_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1732G&#x0003e;T</td><td headers="hd_h_pnpla6-dis.T.pnpla6_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly578Trp</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>PNPLA6</i> encodes the neuropathy target esterase, which belongs to a protein family of nine patatin-like phospholipase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>-containing proteins. Apart from its phospholipid esterase domain (EST; also sometimes called "patatin domain"), the modular architecture of PNPLA6 protein contains three CNB domains (CNB1, CNB2, CNB3).</p><p>The most important functional <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> is the EST domain, which de-esterifies phosphatidylcholine (a major component of biologic membranes) into its constituent fatty acids and glycerophosphocholine [<a class="bk_pop" href="#pnpla6-dis.REF.strickland.1995.667">Strickland et al 1995</a>, <a class="bk_pop" href="#pnpla6-dis.REF.atkins.2002.119">Atkins et al 2002</a>, <a class="bk_pop" href="#pnpla6-dis.REF.van_tienhoven.2002.20942">van Tienhoven et al 2002</a>, <a class="bk_pop" href="#pnpla6-dis.REF.zaccheo.2004.24024">Zaccheo et al 2004</a>]. Glycerophosphocholine serves as a precursor for the biosynthesis of acetylcholine, a key neurotransmitter involved in mediating cellular signaling in the nervous system. Moreover, it has been suggested that the EST domain has a role in lysophospholipase activity [<a class="bk_pop" href="#pnpla6-dis.REF.van_tienhoven.2002.20942">van Tienhoven et al 2002</a>] and functions in lipid membrane metabolism [<a class="bk_pop" href="#pnpla6-dis.REF.tesson.2012.1051">Tesson et al 2012</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Current knowledge suggests that <i>PNPLA6</i> pathogenic variants cause disease by impairing the capacity of the EST <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> to perform ONE of two functions:</p><ul><li class="half_rhythm"><div>De-esterify phosphatidylcholine into fatty acids and glycerophosphocholine (The lack of adequate glycerophosphocholine may disturb development and maintenance of synaptic connections in a variety of neuronal networks.)</div></li><li class="half_rhythm"><div>Catalyze 2-arachidonoyl lysophosphatidylinositol, thus disturbing the metabolism of lipid membranes [<a class="bk_pop" href="#pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</a>, <a class="bk_pop" href="#pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</a>, <a class="bk_pop" href="#pnpla6-dis.REF.kmoch.2015.5614">Kmoch et al 2015</a>]</div></li></ul><p>The EST <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> is altered not only by mutation but also by the toxic effects of organophosphorous compounds [<a class="bk_pop" href="#pnpla6-dis.REF.rainier.2008.780">Rainier et al 2008</a>, <a class="bk_pop" href="#pnpla6-dis.REF.richardson.2013.238">Richardson et al 2013</a>] that are used in industry, agriculture, suicide attempts, chemical warfare, terrorist incidents (1995 Tokyo subway incident), and modification of alcoholic beverages (Jamaica "Ginger Jake" during the Prohibition era) [<a class="bk_pop" href="#pnpla6-dis.REF.richardson.2013.238">Richardson et al 2013</a>].</p></div><div id="pnpla6-dis.References"><h2 id="_pnpla6-dis_References_">References</h2><div id="pnpla6-dis.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.atkins.2002.119">Atkins J, Luthjens LH, Hom ML, Glynn P. Monomers of the catalytic domain of human neuropathy target esterase are active in the presence of phospholipid. <span><span class="ref-journal">Biochem J. </span>2002;<span class="ref-vol">361</span>:119–23.</span> [<a href="/pmc/articles/PMC1222286/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1222286</span></a>] [<a href="/pubmed/11742536" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11742536</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.boucher.1969.507">Boucher BJ, Gibberd FB. Familial ataxia, hypogonadism and retinal degeneration. <span><span class="ref-journal">Acta Neurol Scand. </span>1969;<span class="ref-vol">45</span>:507–10.</span> [<a href="/pubmed/5806782" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5806782</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.daoud.2013.194">Daoud H, Tetreault M, Gibson W, Guerrero K, Cohen A, Gburek-Augustat J, Synofzik M, Brais B, Stevens CA, Sanchez-Carpintero R, Goizet C, Naidu S, Vanderver A, Bernard G. Mutations in POLR3A and POLR3B are a major cause of hypomyelinating leukodystrophies with or without dental abnormalities and/or hypogonadotropic hypogonadism. <span><span class="ref-journal">J Med Genet. </span>2013;<span class="ref-vol">50</span>:194–7.</span> [<a href="/pubmed/23355746" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23355746</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.deik.2014.2411">Deik A, Johannes B, Rucker JC, S&#x000e1;nchez E, Brodie SE, Deegan E, Landy K, Kajiwara Y, Scelsa S, Saunders-Pullman R, Pais&#x000e1;n-Ruiz C. Compound heterozygous PNPLA6 mutations cause Boucher-Neuh&#x000e4;user syndrome with late-onset ataxia. <span><span class="ref-journal">J Neurol. </span>2014;<span class="ref-vol">261</span>:2411–23.</span> [<a href="/pmc/articles/PMC4245359/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4245359</span></a>] [<a href="/pubmed/25267340" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25267340</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.fonteyn.2014.251">Fonteyn EM, Keus SH, Verstappen CC, Schols L, De Groot IJ, Van De Warrenburg BP. The effectiveness of allied health care in patients with ataxia: a systematic review. <span><span class="ref-journal">J Neurol. </span>2014;<span class="ref-vol">261</span>:251–8.</span> [<a href="/pubmed/23589192" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23589192</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.holmes.1907.466">Holmes G. A form of familial degeneration of the cerebellum. <span><span class="ref-journal">Brain. </span>1907;<span class="ref-vol">30</span>:466–89.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.hufnagel.2015.85">Hufnagel RB, Arno G, Hein ND, Hersheson J, Prasad M, Anderson Y, Krueger LA, Gregory LC, Jaworek TJ, Hull S, Li A, Plagnol V, Willen CM, Morgan TM, Prows CA, Hegde RS, Riazuddin S, Grabowski GA, Richardson RJ, Dieterich K, Huang T, Revesz T, Martinez-Barbera JP, Sisk RA, Jefferies C, Houlden H, Dattani MT, Fink JK, Dollfus H, Moore AT, Ahmed ZM. Neuropathy target esterase impairments cause Oliver-McFarlane and Laurence-Moon syndromes. <span><span class="ref-journal">J Med Genet. </span>2015;<span class="ref-vol">52</span>:85–94.</span> [<a href="/pubmed/25480986" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25480986</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.ilg.2014.248">Ilg W, Bastian AJ, Boesch S, Burciu RG, Celnik P, Claassen J, Feil K, Kalla R, Miyai I, Nachbauer W, Schols L, Strupp M, Synofzik M, Teufel J, Timmann D. Consensus paper: management of degenerative cerebellar disorders. <span><span class="ref-journal">Cerebellum. </span>2014;<span class="ref-vol">13</span>:248–68.</span> [<a href="/pmc/articles/PMC4344126/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4344126</span></a>] [<a href="/pubmed/24222635" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24222635</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.ilg.2010.2239">Ilg W, Brotz D, Burkard S, Giese MA, Schols L, Synofzik M. Long-term effects of coordinative training in degenerative cerebellar disease. <span><span class="ref-journal">Mov Disord. </span>2010;<span class="ref-vol">25</span>:2239–46.</span> [<a href="/pubmed/20737551" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20737551</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.ilg.2012.2056">Ilg W, Schatton C, Schicks J, Giese MA, Schols L, Synofzik M. Video game-based coordinative training improves ataxia in children with degenerative ataxia. <span><span class="ref-journal">Neurology. </span>2012;<span class="ref-vol">79</span>:2056–60.</span> [<a href="/pubmed/23115212" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23115212</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.ilg.2009.1823">Ilg W, Synofzik M, Brotz D, Burkard S, Giese MA, Schols L. Intensive coordinative training improves motor performance in degenerative cerebellar disease. <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">73</span>:1823–30.</span> [<a href="/pubmed/19864636" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19864636</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.kmoch.2015.5614">Kmoch S, Majewski J, Ramamurthy V, Cao S, Fahiminiya S, Ren H, MacDonald IM, Lopez I, Sun V, Keser V, Khan A, Str&#x000e1;neck&#x000fd; V, Hartmannov&#x000e1; H, P&#x00159;istoupilov&#x000e1; A, Hoda&#x00148;ov&#x000e1; K, Piherov&#x000e1; L, Kucha&#x00159; L, Baxov&#x000e1; A, Chen R, Barsottini OG, Pyle A, Griffin H, Splitt M, Sallum J, Tolmie JL, Sampson JR, Chinnery P. Care4Rare Canada, Banin E, Sharon D, Dutta S, Grebler R, Helfrich-Foerster C, Pedroso JL, Kretzschmar D, Cayouette M, Koenekoop RK. Mutations in PNPLA6 are linked to photoreceptor degeneration and various forms of childhood blindness. <span><span class="ref-journal">Nat Commun. </span>2015;<span class="ref-vol">6</span>:5614.</span> [<a href="/pmc/articles/PMC4356490/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4356490</span></a>] [<a href="/pubmed/25574898" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25574898</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.krieger.2013.3634">Krieger M, Roos A, Stendel C, Claeys KG, Sonmez FM, Baudis M, Bauer P, Bornemann A, De Goede C, Dufke A, Finkel RS, Goebel HH, Haussler M, Kingston H, Kirschner J, Medne L, Muschke P, Rivier F, Rudnik-Schoneborn S, Spengler S, Inzana F, Stanzial F, Benedicenti F, Synofzik M, Lia Taratuto A, Pirra L, Tay SK, Topaloglu H, Uyanik G, Wand D, Williams D, Zerres K, Weis J, Senderek J. SIL1 mutations and clinical spectrum in patients with Marinesco-Sjogren syndrome. <span><span class="ref-journal">Brain. </span>2013;<span class="ref-vol">136</span>:3634–44.</span> [<a href="/pubmed/24176978" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24176978</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.margolin.2013.1992">Margolin DH, Kousi M, Chan YM, Lim ET, Schmahmann JD, Hadjivassiliou M, Hall JE, Adam I, Dwyer A, Plummer L, Aldrin SV, O'rourke J, Kirby A, Lage K, Milunsky A, Milunsky JM, Chan J, Hedley-Whyte ET, Daly MJ, Katsanis N, Seminara SB. Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination. <span><span class="ref-journal">N Engl J Med. </span>2013;<span class="ref-vol">368</span>:1992–2003.</span> [<a href="/pmc/articles/PMC3738065/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3738065</span></a>] [<a href="/pubmed/23656588" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23656588</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.rainier.2011.19">Rainier S, Albers JW, Dyck PJ, Eldevik OP, Wilcock S, Richardson RJ, Fink JK. Motor neuron disease due to neuropathy target esterase gene mutation: clinical features of the index families. <span><span class="ref-journal">Muscle Nerve. </span>2011;<span class="ref-vol">43</span>:19–25.</span> [<a href="/pubmed/21171093" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21171093</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.rainier.2008.780">Rainier S, Bui M, Mark E, Thomas D, Tokarz D, Ming L, Delaney C, Richardson RJ, Albers JW, Matsunami N, Stevens J, Coon H, Leppert M, Fink JK. Neuropathy target esterase gene mutations cause motor neuron disease. <span><span class="ref-journal">Am J Hum Genet. </span>2008;<span class="ref-vol">82</span>:780–5.</span> [<a href="/pmc/articles/PMC2427280/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2427280</span></a>] [<a href="/pubmed/18313024" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18313024</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.richardson.2013.238">Richardson RJ, Hein ND, Wijeyesakere SJ, Fink JK, Makhaeva GF. Neuropathy target esterase (NTE): overview and future. <span><span class="ref-journal">Chem Biol Interact. </span>2013;<span class="ref-vol">203</span>:238–44.</span> [<a href="/pubmed/23220002" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23220002</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.sapir.2003.387">Sapir S, Spielman J, Ramig LO, Hinds SL, Countryman S, Fox C, Story B. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: a case study. <span><span class="ref-journal">Am J Speech Lang Pathol. </span>2003;<span class="ref-vol">12</span>:387–99.</span> [<a href="/pubmed/14658991" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14658991</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.shi.2014.1013">Shi CH, Schisler JC, Rubel CE, Tan S, Song B, Mcdonough H, Xu L, Portbury AL, Mao CY, True C, Wang RH, Wang QZ, Sun SL, Seminara SB, Patterson C, Xu YM. Ataxia and hypogonadism caused by the loss of ubiquitin ligase activity of the U box protein CHIP. <span><span class="ref-journal">Hum Mol Genet. </span>2014;<span class="ref-vol">23</span>:1013–24.</span> [<a href="/pmc/articles/PMC3900109/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3900109</span></a>] [<a href="/pubmed/24113144" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24113144</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.strickland.1995.667">Strickland JA, Orr GL, Walsh TA. Inhibition of diabrotica larval growth by patatin, the lipid acyl hydrolase from potato tubers. <span><span class="ref-journal">Plant Physiol. </span>1995;<span class="ref-vol">109</span>:667–74.</span> [<a href="/pmc/articles/PMC157634/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC157634</span></a>] [<a href="/pubmed/12228621" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12228621</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.synofzik.2013a.e145">Synofzik M, Bernard G, Lindig T, Gburek-Augustat J. Teaching neuroimages: hypomyelinating leukodystrophy with hypodontia due to POLR3B: Look into a leukodystrophy's mouth. <span><span class="ref-journal">Neurology. </span>2013a;<span class="ref-vol">81</span>:e145</span> [<a href="/pmc/articles/PMC3812106/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3812106</span></a>] [<a href="/pubmed/24190003" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24190003</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.synofzik.2014a.69">Synofzik M, Gonzalez MA, Lourenco CM, Coutelier M, Haack TB, Rebelo A, Hannequin D, Strom TM, Prokisch H, Kernstock C, Durr A, Schols L, Lima-Martinez MM, Farooq A, Schule R, Stevanin G, Marques W Jr, Zuchner S. PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum. <span><span class="ref-journal">Brain. </span>2014a;<span class="ref-vol">137</span>:69–77.</span> [<a href="/pmc/articles/PMC3891450/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3891450</span></a>] [<a href="/pubmed/24355708" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24355708</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.synofzik.2014.583507">Synofzik M, Ilg W. Motor training in degenerative spinocerebellar disease: ataxia-specific improvements by intensive physiotherapy and exergames. <span><span class="ref-journal">Biomed Res Int. </span>2014;<span class="ref-vol">2014</span>:583507</span> [<a href="/pmc/articles/PMC4022207/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4022207</span></a>] [<a href="/pubmed/24877117" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24877117</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.synofzik.2015.580">Synofzik M, Kernstock C, Haack TB, Sch&#x000f6;ls L. Ataxia meets chorioretinal dystrophy and hypogonadism: Boucher-Neuh&#x000e4;user syndrome due to PNPLA6 mutations. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2015;<span class="ref-vol">86</span>:580–1.</span> [<a href="/pubmed/24790214" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24790214</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.synofzik.2013b.2656">Synofzik M, Schatton C, Giese M, Wolf J, Schols L, Ilg W. Videogame-based coordinative training can improve advanced, multisystemic early-onset ataxia. <span><span class="ref-journal">J Neurol. </span>2013b;<span class="ref-vol">260</span>:2656–8.</span> [<a href="/pubmed/23989345" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23989345</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.synofzik.2014b.57">Synofzik M, Sch&#x000fc;le R, Schulze M, Gburek-Augustat J, Schweizer R, Schirmacher A, Kr&#x000e4;geloh-Mann I, Gonzalez M, Young P, Z&#x000fc;chner S, Sch&#x000f6;ls L, Bauer P. Phenotype and frequency of STUB1 mutations: next-generation screenings in Caucasian ataxia and spastic paraplegia cohorts. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2014b;<span class="ref-vol">9</span>:57.</span> [<a href="/pmc/articles/PMC4021831/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4021831</span></a>] [<a href="/pubmed/24742043" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24742043</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.tarnutzer.2015.194">Tarnutzer AA, Gerth-Kahlert C, Timmann D, Chang DI, Harmuth F, Bauer P, Straumann D, Synofzik M. Boucher-Neuhauser syndrome: cerebellar degeneration, chorioretinal dystrophy and hypogonadotropic hypogonadism: two novel cases and a review of 40 cases from the literature. <span><span class="ref-journal">J Neurol. </span>2015;<span class="ref-vol">262</span>:194–202.</span> [<a href="/pubmed/25359264" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25359264</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.tesson.2012.1051">Tesson C, Nawara M, Salih MA, Rossignol R, Zaki MS, Al Balwi M, Schule R, Mignot C, Obre E, Bouhouche A, Santorelli FM, Durand CM, Oteyza AC, El-Hachimi KH, Al Drees A, Bouslam N, Lamari F, Elmalik SA, Kabiraj MM, Seidahmed MZ, Esteves T, Gaussen M, Monin ML, Gyapay G, Lechner D, Gonzalez M, Depienne C, Mochel F, Lavie J, Schols L, Lacombe D, Yahyaoui M, Al Abdulkareem I, Zuchner S, Yamashita A, Benomar A, Goizet C, Durr A, Gleeson JG, Darios F, Brice A, Stevanin G. Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">91</span>:1051–64.</span> [<a href="/pmc/articles/PMC3516610/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3516610</span></a>] [<a href="/pubmed/23176821" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23176821</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.van_tienhoven.2002.20942">van Tienhoven M, Atkins J, Li Y, Glynn P. Human neuropathy target esterase catalyzes hydrolysis of membrane lipids. <span><span class="ref-journal">J Biol Chem. </span>2002;<span class="ref-vol">277</span>:20942–8.</span> [<a href="/pubmed/11927584" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11927584</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.yoon.2013.181">Yoon G, Baskin B, Tarnopolsky M, Boycott KM, Geraghty MT, Sell E, Goobie S, Meschino W, Banwell B, Ray PN. Autosomal recessive hereditary spastic paraplegia-clinical and genetic characteristics of a well-defined cohort. <span><span class="ref-journal">Neurogenetics. </span>2013;<span class="ref-vol">14</span>:181–8.</span> [<a href="/pubmed/23733235" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23733235</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pnpla6-dis.REF.zaccheo.2004.24024">Zaccheo O, Dinsdale D, Meacock PA, Glynn P. Neuropathy target esterase and its yeast homologue degrade phosphatidylcholine to glycerophosphocholine in living cells. <span><span class="ref-journal">J Biol Chem. </span>2004;<span class="ref-vol">279</span>:24024–33.</span> [<a href="/pubmed/15044461" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15044461</span></a>]</div></li></ul></div></div><div id="pnpla6-dis.Chapter_Notes"><h2 id="_pnpla6-dis_Chapter_Notes_">Chapter Notes</h2><div id="pnpla6-dis.Acknowledgments"><h3>Acknowledgments</h3><p>This work was supported by the Interdisciplinary Center for Clinical Research IZKF T&#x000fc;bingen (Grant 2191-0-0 to MS), U54NS0657, R01NS075764, R01NS072248, the MDA, and the CMT Association.</p></div><div id="pnpla6-dis.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>11 June 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>9 October 2014 (me) Review posted live</div></li><li class="half_rhythm"><div>29 May 2014 (ms) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK247161</span><span class="label">PMID: <a href="/pubmed/25299038" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">25299038</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cdg-1a/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/alpers/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK247161&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK247161/?report=reader">PubReader</a></li><li><a href="/books/NBK247161/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK247161" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK247161" style="display:none" title="Cite this Page"><div class="bk_tt">Synofzik M, Hufnagel RB, Züchner S. PNPLA6-Related Disorders. 2014 Oct 9 [Updated 2015 Jun 11]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK247161/pdf/Bookshelf_NBK247161.pdf">PDF version of this page</a> (219K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#pnpla6-dis.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#pnpla6-dis.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#pnpla6-dis.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#pnpla6-dis.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#pnpla6-dis.Genetically_Related_Allelic_D" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#pnpla6-dis.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#pnpla6-dis.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#pnpla6-dis.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#pnpla6-dis.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#pnpla6-dis.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#pnpla6-dis.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#pnpla6-dis.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=54476[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">RNF216</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10908[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PNPLA6</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=3300512" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=3300512" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=3300512" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=3300512" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24355708" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum.</a><span class="source">[Brain. 2014]</span><div class="brieflinkpop offscreen_noflow">PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Synofzik M, Gonzalez MA, Lourenco CM, Coutelier M, Haack TB, Rebelo A, Hannequin D, Strom TM, Prokisch H, Kernstock C, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Brain. 2014 Jan; 137(Pt 1):69-77. Epub 2013 Dec 19.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25480986" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Neuropathy target esterase impairments cause Oliver-McFarlane and Laurence-Moon syndromes.</a><span class="source">[J Med Genet. 2015]</span><div class="brieflinkpop offscreen_noflow">Neuropathy target esterase impairments cause Oliver-McFarlane and Laurence-Moon syndromes.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hufnagel RB, Arno G, Hein ND, Hersheson J, Prasad M, Anderson Y, Krueger LA, Gregory LC, Stoetzel C, Jaworek TJ, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Med Genet. 2015 Feb; 52(2):85-94. Epub 2014 Dec 5.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29248984" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Different Cerebellar Ataxia Phenotypes Associated with Mutations of the PNPLA6 Gene in Brazilian Patients with Recessive Ataxias.</a><span class="source">[Cerebellum. 2018]</span><div class="brieflinkpop offscreen_noflow">Different Cerebellar Ataxia Phenotypes Associated with Mutations of the PNPLA6 Gene in Brazilian Patients with Recessive Ataxias.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Teive HAG, Camargo CHF, Sato MT, Shiokawa N, Boguszewski CL, Raskin S, Buck C, Seminara SB, Munhoz RP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Cerebellum. 2018 Jun; 17(3):380-385. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301718" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLA2G6</i>-Associated Neurodegeneration</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLA2G6</i>-Associated Neurodegeneration<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gregory A, Kurian MA, Maher ER, Hogarth P, Hayflick SJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301509" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Balasubramanian R, Crowley WF Jr. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=25299038" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=25299038" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04122edde0891169a7a872">PNPLA6-Related Disorders - GeneReviews®</a><div class="ralinkpop offscreen_noflow">PNPLA6-Related Disorders - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:51:43-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8CE4A0E0411AC1000000000035000F&amp;ncbi_session=CE8CE4A0E04122E1_0053SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK247161%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK247161&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK247161/&amp;ncbi_pagename=PNPLA6-Related Disorders - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8CE4A0E04122E1_0053SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>